Antidepressant medicines have other side effects. Anyone considering the use of LUVOX® CR (fluvoxamine maleate) Extended-Release Capsules or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Subgroup analyses generally luvox prescribing info not indicate differences in treatment outcomes as a function of age, race, or gender. Dose adjustment in adolescents (up to the adult maximum dose of 300 mg) may be indicated to achieve therapeutic benefit. The efficacy of Luvox CR Capsules was demonstrated in one 12-week trial with obsessive compulsive outpatients with the diagnosis of OCD as defined in DSM-IV (see Clinical Trials under CLINICAL PHARMACOLOGY). Anyone considering the use of Luvox CR Capsules in a child or adolescent must balance the potential risks with the clinical need. No overall differences in safety were observed between these patients and younger patients. Fluvoxamine acid and fluvoxethanol were tested in an in vitro assay of serotonin and norepinephrine reuptake inhibition in rats; they were inactive except for a weak effect of the former metabolite on inhibition of luvox prescribing info uptake luvox prescribing info luvox prescribing info of magnitude less potent than the parent compound).
luvox and allergic reaction
All patients had moderate-to-severe OCD (DSM-III-R) with mean baseline ratings on the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) total score of 24. Patients in this study were luvox prescribing info to a total daily fluvoxamine dose of approximately 100 mg/day over the first two weeks of the trial, following which the dose was adjusted within a range of 50 mg/day to 200 mg/day (given in two doses per day) on the basis luvox prescribing info response and tolerance. Digoxin: Administration of immediate-release fluvoxamine maleate tablets 100 mg daily for 18 days (N = 8) did not significantly affect the pharmacokinetics of a 1.25 mg single intravenous dose of digoxin. Avoid temperatures above 86 degrees F (30 degrees C). The metabolism of fluvoxamine has not been fully characterized and the effects of potent cytochrome P450 isoenzyme inhibition, luvox prescribing info as the ketoconazole inhibition of CYP3A4, on fluvoxamine metabolism have not been studied. 2Based on the number of males. Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk (see Geriatric Use). Based on a finding of substantial interactions of fluvoxamine with certain of these drugs (see later parts of this section and also WARNINGS for details) and limited in vitro data for CYP3A4, it appears that fluvoxamine inhibits several cytochrome P450 isoenzymes that are known to be involved in the metabolism of other drugs such as: CYP1A2 (e.g. The obsessions or compulsions cause marked distress, luvox prescribing info time-consuming, or significantly interfere with social or occupational functioning. Comparisons of immediate-release fluvoxamine maleate tablets or Luvox CR Capsules versus placebo groups in separate short-term trials on (1) median change from baseline on various vital signs variables and on (2) incidence of patients meeting criteria for potentially important changes from baseline on various measures of vital signs variables revealed luvox prescribing info important differences between fluvoxamine maleate and placebo. You may also report side effects at http://www.fda.gov/medwatch. Special Populations Dosage for Elderly or Hepatically Impaired Patients Elderly patients and those with hepatic impairment have been observed to have a decreased clearance luvox prescribing info fluvoxamine maleate. This table shows the percentage of patients in each group who had at least one occurrence of an event at some time during their treatment. Before taking fluvoxamine, tell your doctor if you have: liver disease; seizures or epilepsy; bipolar disorder (manic depression); or a history of drug abuse or suicidal thoughts. 2 GELATIN FERRIC OXIDE RED TALC TITANIUM DIOXIDE Product Characteristics Color BLUE (dark blue opaque cap/white opaque body) Score no score Shape CAPSULE (two-piece gelatin capsule) Size 19mm Flavor Imprint Code LCR;100 Contains Packaging # NDC Package Description Multilevel Packaging 1 68727-600-01 30 CAPSULE In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA022033 02/28/2008 Luvox CR fluvoxamine maleate capsule, extended release Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) luvox prescribing info Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FLUVOXAMINE MALEATE (FLUVOXAMINE) FLUVOXAMINE MALEATE 150 mg Inactive Ingredients Ingredient Name Strength DIBUTYL SEBACATE FD&C BLUE NO. The no effect dose for fertility impairment was 60 mg/kg (approximately 2 times the maximum recommended human dose on a mg/m2 basis). Lesser degrees of performance anxiety or shyness generally do not require psychopharmacological treatment. Check with your doctor if any of these most COMMON side effects persist or become bothersome: Constipation; decreased sexual ability; diarrhea; dizziness; drowsiness; dry mouth; gas; headache; increased sweating; loss of appetite; nausea; nervousness; sore throat; stomach upset; trouble sleeping; vomiting; weakness. Check with your doctor if any of these most COMMON side effects persist or become bothersome: Constipation; decreased sexual ability; diarrhea; dizziness; drowsiness; dry mouth; gas; headache; increased sweating; loss of appetite; nausea; nervousness; sore throat; stomach upset; trouble sleeping; vomiting; weakness.
Musculoskeletal System: Infrequent: arthralgia, arthritis, bursitis, generalized muscle spasm, myasthenia, tendinous contracture, tenosynovitis; Rare: arthrosis, myopathy, luvox prescribing info fracture. Clozapine: Elevated serum levels of clozapine have been reported in patients taking immediate-release fluvoxamine maleate tablets and clozapine. Children, teenagers, and young adults who take Luvox CR Extended-Release Capsules may be at increased risk for suicidal thoughts or actions. The structural formula is: Fluvoxamine maleate is a white to off-white, odorless, crystalline powder that is sparingly soluble in water, luvox prescribing info soluble in ethanol and chloroform and practically insoluble in diethyl ether. Severe vomiting has been reported with the co-administration of immediate-release fluvoxamine maleate tablets and tryptophan. Tricyclic Antidepressants (TCAs): Significantly increased plasma TCA levels have been reported with the co-administration of immediate-release fluvoxamine maleate tablets and amitriptyline, clomipramine, or imipramine. Some of these medications can cause serious or life-threatening drug interactions when taken together with fluvoxamine. Some of these medications can cause serious or life-threatening drug interactions when luvox prescribing info within 14 days before or after taking fluvoxamine. Clinical Worsening and Suicide Risk: Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Activation of mania/hypomania has also been reported in a small proportion of patients with major affective disorder who were treated with other marketed antidepressants. However, if it is almost time for the next regularly scheduled dose, skip the missed dose and take the next one as directed. The proposed mechanism for the development of hyponatremia involves the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) via release of antidiuretic hormone. Top More Luvox CR resources Luvox CR luvox prescribing info Information (FDA) Luvox CR Concise Consumer Information (Cerner Multum) Luvox CR Advanced Consumer (Micromedex) - Includes Dosage Information Luvox CR Extended-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer) Fluvoxamine Prescribing Information (FDA) Fluvoxamine MedFacts Consumer Leaflet (Wolters Kluwer). Safety and effectiveness in the pediatric population other than pediatric patients with OCD have not been established (see BOXED WARNING and WARNINGS – Clinical Worsening and Suicide Risk).